EDGEMOND JAMES sold UTHR
December 1, 2025 · Form 4 insider transaction
EDGEMOND JAMES sold 20,483 shares of United Therapeutics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
20,483
Price
$0.00
Total value
N/A
InsiderEDGEMOND JAMES
RoleOfficer
SecurityStock Option
Transaction codeM: Option exercise
Transaction dateDecember 1, 2025
Filing dateDecember 2, 2025
Shares owned after24,517
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 5, 2025.